Lack of renoprotective effect of i.v. N-acetylcysteine in patients with chronic renal failure [9]

British Journal of Anaesthesia

Volumn 99, Issue 1, 2007, Pages 143-144

  Ristikankare, Anne ^a   Kuitunen, T ^a   Kuitunen, A ^a   Uotila, L ^a   Vento, A ^a   Suojaranta Ylinen, R ^a   Salmenpera M ^a   Poyhia R ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLCYSTEINE; CREATININE; INFUSION FLUID; NONSTEROID ANTIINFLAMMATORY AGENT; ACETYLSALICYLIC ACID; CONTRAST MEDIUM; N ACETYL BETA GLUCOSAMINIDASE; PLACEBO;

CAUSE OF DEATH; CONTROLLED STUDY; CREATININE BLOOD LEVEL; DIAGNOSTIC ACCURACY; FEMALE; GLOMERULUS FILTRATION RATE; HEART DISEASE; HEART SURGERY; HEMODIALYSIS; HEMOFILTRATION; HUMAN; HYDRATION; HYPOVOLEMIA; INTENSIVE CARE UNIT; KIDNEY FAILURE; KIDNEY INJURY; LABORATORY TEST; LENGTH OF STAY; LETTER; LUNG PRESSURE; MALE; MULTIPLE ORGAN FAILURE; PREOPERATIVE EVALUATION; PRIORITY JOURNAL; REFERENCE VALUE; RENAL REPLACEMENT THERAPY; RISK ASSESSMENT; SURGICAL RISK; ACUTE KIDNEY FAILURE; CHRONIC KIDNEY FAILURE; EVIDENCE BASED MEDICINE; METHODOLOGY; NOTE; BLEEDING; CARDIOPULMONARY BYPASS; CLINICAL TRIAL; CORONARY ARTERY BYPASS SURGERY; CREATININE CLEARANCE; DRUG EFFICACY; DRUG SAFETY; HEART VALVE SURGERY; NEPHROTOXICITY; RENAL PROTECTION;

ACETYLCYSTEINE; CARDIAC SURGICAL PROCEDURES; EVIDENCE-BASED MEDICINE; HUMANS; KIDNEY FAILURE, ACUTE; KIDNEY FAILURE, CHRONIC; RESEARCH DESIGN;

EID: 34447511612     PISSN: 00070912     EISSN: 14716771     Source Type: Journal    
DOI: 10.1093/bja/aem151     Document Type: Letter

References (7)

1. Ristikankare A, Kuitunen T, Kuitunen A, et al. Lack of renoprotective effect of i.v. N-acetylcysteine in patients with chronic renal failure undergoing cardiac surgery. Br J Anaesth 2006; 97: 611-6
2. Zagler A, Azadpour M, Mercado C, Hennekens CH. N-Acetylcysteine and contrast induced nephropathy: A meta-analysis of thirteen randomised trials. Am Heart J 2006; 151: 140-5
3. Wang F, Dupuis JY, Nathan H, Williams K. An analysis of the association between preoperative renal dysfunction and outcome in cardiac surgery: estimated creatinine clearance or plasma creatinine level as measures of renal function. Chest 2003; 124: 1852-62
4. Tepel M, van der Giet M, Schwarzfeld C, et al. Prevention of radiographic-contrast-agent-induced reductions in renal function by acetylcysteine. N Engl J Med 2000; 343: 180-4
5. Burns KEA, Chu MWA, Novick RJ, et al. Perioperative N-acetylcysteine to prevent renal dysfunction in high-risk patients undergoing cabg surgery: A randomized controlled trial. JAMA 2005; 294: 342-50
6. Wijeysundera DN, Karkouti K, Beattie WS, et al. Improving the identification of patients at risk of postoperative renal failure after cardiac surgery. Anesthesiology 2006; 104: 65-72
7. Niemi TT, Munsterhjelm E, Poyhia R, et al. The effect of N-acetylcysteine on blood coagulation and platelet function in patients undergoing open repair of abdominal aortic aneurysm. Blood Coagul Fibrinolysis 2006; 17: 29-34